Cellectar Biosciences Inc (NASDAQ:CLRB)
| 2.24 Delayed Data As of Nov 29 |  +0.01 / +0.45%Today’s Change | 1.25 Today|||52-Week Range 3.15 | +30.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -5.5M | -6.2M | -13.6M | -13.2M | |
| Depreciation | 362.5K | 356.7K | 1.5M | 82.3K | ||
| Total Other Cash Flow | -2.8M | -2.7M | 736.7K | 2.3M | ||
| Funds From Operations | -7.9M | -8.6M | -11.3M | -10.9M | ||
| Funds From/For Other Operating Expenses | 265.5K | -273.8K | -259.3K | 569.1K | ||
| Net Cash Flow - Operating Activities | -8.2M | -8.3M | -11.0M | -11.4M | ||
| Investing | Capital Expenditures | -58.5K | -72.3K | -346.7K | -385.0K | |
| Fixed Asset Disposal | -- | -- | -- | 55.0K | ||
| Net Cash Flow Investing | -58.5K | -72.3K | -346.7K | -330.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -122.7K | -246.1K | -89.3K | -3.0K | ||
| Net Proceeds Stock Sale | 2.9M | 16.1M | 10.0M | 15.0M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -762.00 | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 594.00 | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | 2.7M | 15.9M | 9.9M | 15.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -5.6M | 7.6M | -1.4M | 3.2M | ||
